A recent study found the use of an alert and a request for more clinical information in a multisite health system’s electronic health record (EHR) system led to a 12 percent reduction in contrast-enhanced computed tomography (CT) exams per day and a 15.2 percent reduction in orders for CT with contrast media per day.
Catch up on the top radiology content of the past week.
The system has an open architectural design to allow for third-party integrations.
Artificial intelligence (AI) accurately diagnosed 79 percent of proximal large vessel occlusions with an ipsiversive gaze deviation on non-contrast computed tomography (CT), according to new research findings presented recently at the Society of Neurointerventional Surgery’s (SNIS) 19th Annual Meeting in Toronto.
The imaging agent is approved for use in 50 countries in Europe and Asia, but is not currently approved in the US.
Catch up on the top radiology content of the past week.
In a video interview, Morris Panner, the president of Intelerad Medical Systems, discussed key observations from the recent Society for Imaging Informatics in Medicine (SIIM) conference, recent research about artificial intelligence (AI) adoption and emerging goals for enhancing the efficiency of radiology workflows.
The Food and Drug Administration (FDA) has given the green light to Bayer to import foreign-labeled iopromide (Ultravist) to help alleviate ongoing supply challenges with iodinated contrast media in the United States.
Emerging research shows the use of preoperative computed tomography (CT) led to improved success rates with device implantation, reduced procedure time and less device size changes in comparison to standalone transesophageal echocardiogram (TEE) for left atrial appendage occlusion (LAAO) procedures.
In a video interview, Jonathan Dillman, MD, MSc discussed a recently published statement from the American College of Radiology (ACR) that questioned the literature support for a March guidance from the Food and Drug Administration (FDA) about thyroid monitoring for children three years of age or younger within three weeks of exposure to iodinated contrast media (ICM).
Catch up on the top radiology news of the past week.
Catch up on the top radiology news of the past week.
As the iodinated contrast media shortage continues to have a significant adverse effect on radiology, these authors assess the pros and cons of emerging strategies and imaging alternatives.
Catch up on the top radiology content of the past week.
In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.
Whether it is humorous associations with common terminology, oddities on X-rays or decidedly uncomfortable imaging findings, this author shares a few chuckles from his experience.
The newly FDA-cleared Symbia Pro.specta SPECT/CT Scanner, which reportedly offers a variety of enhanced capabilities including low-dose CT up to 64 slices and intuitive workflow guides, was launched at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting.
The new workload management system reportedly emphasizes predictive analytics to facilitate efficient workload distribution and increase reading capacity for radiologists.
In a newly published statement, the American College of Radiology cited questionable literature support for the recent FDA guidance and noted potential consequences ranging from diagnosis delays due to parental anxiety about contrast-enhanced computed tomography (CECT) and increased health care costs.
Do we settle for oblique truths more often than not to mitigate potential repercussions?
Catch up on the top radiology content of the past week.
In a recent video interview on the current iodinated contrast media shortage, neuroradiologist Sean Bryant, MD discussed imaging alternatives, emphasized communication with referring physicians on optimal studies, and discussed the ongoing need to prevent “protocol creep” with timely updates of imaging protocols.
The resumed production of GE Healthcare’s Omnipaque products is a welcome development for radiologists scrambling to come up with alternative dosing and imaging options in the past month during the temporary shortage of iodinated contrast media.
In an ongoing quest to reduce the impact of the temporary iodinated contrast media (ICM) shortage, a group of researchers recently examined Medicare claims data to identify high-frequency usage patterns of contrast-enhanced computed tomography (CECT) services.
Catch up on the top radiology content of the past week.
